| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Apr―11 |
Prophylactic effects of nirmatrelvir/ritonavir on reducing complications of cardiac surgery, reinfection, and post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with previous SARS-CoV-2 infection: a randomized clinical trial (PEP Trial) |
Xin Yuan, Lihua Zhang, Jingkuo Li, Lubi Lei, Kai Chen, Qing Chu, et al. (+14) Wei Feng, Xiaoqi Wang, Zhaoyun Cheng, Yan Yang, Yang Wang, Hansong Sun, Yunhu Song, Sheng Liu, Xianqiang Wang, Shuiyun Wang, Liqing Wang, Xin Wang, Fei Xu, Shengshou Hu |
| 2 |
[GO] |
2025―Apr―06 |
Targeting SARS-CoV-2 NSP14 with TDI-015051: a new frontier in antiviral therapy |
Guoxiang Li, Yiran Wu, Fangfang Zhou |
| 3 |
[GO] |
2025―Apr―03 |
Efficacy and safety of an mRNA encoding neutralizing antibody against SARS-CoV-2 in non-human primates |
Hang Chi, Suo-Qun Zhao, Yun-Peng Liu, Xiao-Chuan Xiong, Xia Zhong, Xing-Xing Suo, et al. (+15) Xing-Yao Huang, Can Yue, Jing-Jing Zhang, Zhe Cong, Na Li, Fei-Xue Du, Ting Chen, Jian-Rong Ma, Lei Wang, Bo Ying, Yong-Qiang Deng, Ji-Ye Yin, Xiangxi Wang, Jing Xue, Cheng-Feng Qin |
| 4 |
[GO] |
2025―Mrz―01 |
Pivotal roles of intracellular Cl- in COVID-19: pathogenesis and therapeutic targets |
Su Qu, Lei Chen, Jie Sheng, Xiao-Chun Hou, Wen-Liang Zhou, Nan-Shan Zhong, Yi-Lin Zhang |
| 5 |
[GO] |
2024―Aug―23 |
Mitigated transmission and health impact of COVID-19 in Beijing, China during spring 2024: comparison with the global trends |
Ying Shen, Zhaomin Feng, Daitao Zhang, Xiaoli Wang, Ying Sun, Fu Li, et al. (+5) Li Zhang, Jiaojiao Zhang, Chunna Ma, Peng Yang, Quanyi Wang |
| 6 |
[GO] |
2024―Jul―20 |
Enhancing Immune Defense Against COVID-19: Alveolar Delivery of Mucosal Vaccines |
Pei-Huang Wu, Dong-Chun Hong, Chu Xie, Mu-Sheng Zeng, Cong Sun |
| 7 |
[GO] |
2024―Jul―15 |
Longitudinal landscape of immune reconstitution after acute SARS-CoV-2 infection at single-cell resolution |
Lili Ren, Yiwei Liu, Yeming Wang, Chao Wu, Li Guo, Lan Chen, et al. (+18) Xinming Wang, Yan Xiao, Lixue Huang, Jingchuan Zhong, Jiacheng Yao, Lu Liu, Hui Li, Ying Wang, Yongchao Ma, Yichunzi Zhang, Lin Di, Tao Dong, Julian Knight, Jianbin Wang, Yanyi Huang, Bin Cao, Xianwen Ren, Jianwei Wang |
| 8 |
[GO] |
2024―Jun―12 |
Development of T cell antigen-based human coronavirus vaccines against nAb-escaping SARS-CoV-2 variants |
Hao Zhou, Ping Leng, Yang Wang, Kaiwen Yang, Chen Li, David M. Ojcius, et al. (+2) Pengfei Wang, Shibo Jiang |
| 9 |
[GO] |
2024―Mai―29 |
Single-cell multi-omics analysis revealing immune features of inactivated COVID-19 vaccination in systemic lupus erythematosus patients |
Yuxuan Zheng, Siyuan Wang, Xingyu Zhou, Shitong Qiao, Xin Zhao, Yuan Chen, et al. (+6) Zijun Li, Zhanguo Li, Xiaolin Sun, Shuguang Tan, Jing He, George F. Gao |
| 10 |
[GO] |
2024―Mai―03 |
T Cell Senescence May Contribute to Immunothrombosis via Th17 Immune Transition in COVID-19 |
Wenxing Li, Rui Qian, Zhaoming Zhou, Lei Wen, Quan Yin, Xiang Zhou, et al. (+19) Xiaowei Li, Jie Cheng, Xinlu Zhang, Xin Zeng, Zhuoya Wang, Yingying Huang, Shengqiang Wang, Yixing Liao, Youjiang Li, Shenbing Shan, Meijuan Zhou, Wu Wei, Amir Abdollahi, Avery August, Nicholas Magazine, Gianluca Veggiani, Weishan Huang, Daogang Guan, Cheng Zhou |
| 11 |
[GO] |
2024―Apr―23 |
Effectiveness and safety of Sanhan Huashi granules versus nirmatrelvir-ritonavir in adult patients with COVID-19: A randomized, open-label, multicenter trial |
Xiaohui Zou, Kang Chang, Guohui Fan, Huanwei Zheng, Hezheng Shen, Liang Tang, et al. (+9) Yingying Yang, Yeming Wang, Linhua Zhao, Hong Lv, Xin Zhou, Xiaoming Shen, Liqiang Chen, Xiaolin Tong, Bin Cao |
| 12 |
[GO] |
2023―Nov―14 |
Preclinical evaluation of RQ3013, a broad-spectrum mRNA vaccine against SARS-CoV-2 variants |
Shudan Tan, Jinghua Zhao, Xue Hu, Yufeng Li, Zihan Wu, Guoliang Lu, et al. (+26) Zhaoli Yu, Binhe Du, Yan Liu, Li Li, Yuchen Chen, Ye Li, Yanfeng Yao, Xiaoyu Zhang, Juhong Rao, Ge Gao, Yun Peng, Hang Liu, Zhiming Yuan, Jia Liu, Qianran Wang, Hengrui Hu, Xiaobo Gao, Hui Zhou, Hang Yu, Yingjie Xu, Wei Yu, Lin Feng, Manli Wang, Chao Shan, Jing Lu, Jinzhong Lin |
| 13 |
[GO] |
2023―Nov―10 |
Quantitative single-virus tracking for revealing the dynamics of SARS-CoV-2 fusion with plasma membrane |
Hao-Yang Liu, Yusi Hu, Cong Yu, Zhi-Gang Wang, Shu-Lin Liu, Dai-Wen Pang |
| 14 |
[GO] |
2023―Nov―03 |
Spatially resolved transcriptomics reveals distinct pulmonary immune responses during influenza virus and SARS-CoV-2 infections |
Min Zhao, Fei Shao, Zhen Liu, Jiangwen Ma, Dou Yu, Hangjie Zhang, et al. (+6) Lianpan Dai, Kun Xu, Xin Zhao, Mengli Zheng, George F. Gao, Shuo Wang |
| 15 |
[GO] |
2023―Okt―04 |
Classification of five SARS-CoV-2 serotypes based on RBD antigenicities |
Shixiong Hu, Chunli Wu, Xinkai Wu, Xuehui Ma, Chang Shu, Qian Chen, et al. (+6) Anqi Zheng, Huiting Yang, Jian Lu, Pei Du, George Fu Gao, Qihui Wang |
| 16 |
[GO] |
2023―Sep―12 |
Discovery and identification of a novel canine coronavirus causing a diarrhea outbreak in Vulpes |
Yuting Liu, Yao Deng, Sheng Niu, Na Zhu, Jingdong Song, Xiaoshuang Zhang, et al. (+9) Weiting Su, Wenhui Nie, Roujian Lu, David M. Irwin, George Fu Gao, Wenling Wang, Qihui Wang, Wenjie Tan, Shuyi Zhang |
| 17 |
[GO] |
2023―Aug―15 |
Single particle tracking reveals SARS-CoV-2 regulating and utilizing dynamic filopodia for viral invasion |
Yue Zhang, Xiaowei Zhang, Zhongyi Li, Weisong Zhao, Hui Yang, Shuangshuang Zhao, et al. (+10) Daijiao Tang, Qian Zhang, Zonghong Li, Huisheng Liu, Haoyu Li, Bo Li, Pekka Lappalainen, Tao Xu, Zongqiang Cui, Yaming Jiu |
| 18 |
[GO] |
2022―Okt―27 |
Antiviral drug design based on structural insights into the N-terminal domain and C-terminal domain of the SARS-CoV-2 nucleocapsid protein |
Xiaodong Luan, Xinming Li, Yufan Li, Gengchen Su, Wanchao Yin, Yi Jiang, et al. (+8) Ning Xu, Feng Wang, Wang Cheng, Ye Jin, Leike Zhang, H. Eric Xu, Yi Xue, Shuyang Zhang |
| 19 |
[GO] |
2022―Okt―26 |
Addressing mental health issues amid the COVID-19 pandemic: a wake-up call |
Yimiao Gong, Xiaoxing Liu, Sizhen Su, Yanping Bao, Thomas R. Kosten, Lin Lu |
| 20 |
[GO] |
2022―Aug―05 |
Biochips under COVID-19: a new stage of well-grounded development and accelerated translation |
Jiajia Liu, Youchun Xu, Jing Cheng |
| 21 |
[GO] |
2022―Jun―30 |
Sustained abnormality with recovery of COVID-19 convalescents: a 2-year follow-up study |
Hao Lin, Xueyuan Liu, Heqiang Sun, Jie Zhang, Shaobo Dong, Maoshun Liu, et al. (+17) Lei Li, Jinmin Tian, Yaxin Guo, Jinxian Gan, Zhangfu Chen, Xin Wang, Ying Lin, Danni Zhang, Yaning Liu, Xiaoshan Zhang, Peipei Liu, Ke Xu, Xiangtian Zhou, Hao Liang, George F. Gao, William J. Liu, Guizhen Wu |
| 22 |
[GO] |
2022―Mai―26 |
A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2 |
Junyu Chen, Pui Wang, Lunzhi Yuan, Liang Zhang, Limin Zhang, Hui Zhao, et al. (+30) Congjie Chen, Xijing Wang, Jinle Han, Yaode Chen, Jizong Jia, Zhen Lu, Junping Hong, Zicen Lu, Qian Wang, Rirong Chen, Ruoyao Qi, Jian Ma, Min Zhou, Huan Yu, Chunlan Zhuang, Xiaohui Liu, Qiangyuan Han, Guosong Wang, Yingying Su, Quan Yuan, Tong Cheng, Ting Wu, Xiangzhong Ye, Tianying Zhang, Changgui Li, Jun Zhang, Huachen Zhu, Yixin Chen, Honglin Chen, Ningshao Xia |
| 23 |
[GO] |
2022―Apr―03 |
Wastewater as an information source of COVID-19 |
Tong Zhang |
| 24 |
[GO] |
2022―Mrz―26 |
Enhanced hand-to-mouth exposure from hand sanitizers during the COVID-19 pandemic: a case study of triclosan |
Meilin Wang, Boyuan Hu, Wei Zhou, Kai Huang, Jianjie Fu, Aiqian Zhang, Guibin Jiang |
| 25 |
[GO] |
2022―Feb―19 |
COVID-19 can be called a treatable disease only after we have antivirals |
Xueyang Zhang, Peter Horby, Bin Cao |
| 26 |
[GO] |
2022―Feb―12 |
Azacytidine targeting SARS-CoV-2 viral RNA as a potential treatment for COVID-19 |
Xian Lin, Xianliang Ke, Xiaoqin Jian, Lin Xia, Yang Yang, Tianying Zhang, et al. (+5) Hualong Xiong, Binghai Zhao, Wen Liu, Quanjiao Chen, Chong Tang |
| 27 |
[GO] |
2022―Jan―10 |
An interactive viral genome evolution network analysis system enabling rapid large-scale molecular tracing of SARS-CoV-2 |
Yunchao Ling, Ruifang Cao, Jiaqiang Qian, Jiefu Li, Haokui Zhou, Liyun Yuan, et al. (+7) Zhen Wang, Liangxiao Ma, Guangyong Zheng, Guoping Zhao, Zefeng Wang, Guoqing Zhang, Yixue Li |
| 28 |
[GO] |
2021―Dez―14 |
Filtration efficiency of face masks against aerosolized surrogate SARS-CoV-2 at different social distances |
Song Tang, Xia Li, Pei Ding, Yixin Mao, Fuchang Deng, Yu'e Cha, et al. (+10) Siqi Zhuang, Cheng Ding, Jiao Wang, Youbin Wang, Xiaoning Zhao, Rachael M. Jones, Biao Kan, C. Raina MacIntyre, Dongqun Xu, Xiaoming Shi |
| 29 |
[GO] |
2021―Nov―30 |
The effects of different travel modes and travel destinations on COVID-19 transmission in global cities |
Rui Zhu, Luc Anselin, Michael Batty, Mei-Po Kwan, Min Chen, Wei Luo, et al. (+9) Tao Cheng, Che Kang Lim, Paolo Santi, Cheng Cheng, Qiushi Gu, Man Sing Wong, Kai Zhang, Guonian Lü, Carlo Ratti |
| 30 |
[GO] |
2021―Aug―28 |
Cell perturbation in choroid plexus and cortex aiding COVID-19 neurological symptoms |
Xiao-Yuan Mao, Wei-Lin Jin |
| 31 |
[GO] |
2021―Jul―27 |
Inactivated SARS-CoV-2 vaccine does not influence the profile of prothrombotic antibody nor increase the risk of thrombosis in a prospective Chinese cohort |
Tingting Liu, Jing Dai, Zhitao Yang, Xiaoqi Yu, Yanping Xu, Xinming Shi, et al. (+12) Dong Wei, Zihan Tang, Guanqun Xu, Wenxin Xu, Yu Liu, Ce Shi, Qi Ni, Chengde Yang, Xinxin Zhang, Xuefeng Wang, Erzhen Chen, Jieming Qu |
| 32 |
[GO] |
2021―Jun―12 |
Fingerprint of COVID-19 in arctic sea ice changes |
Zhuoqi Chen, Shaoyin Wang, Yufang Ye, Jiping Liu, Georg Heygster, Mohammed Shokr, et al. (+2) Fengming Hui, Xiao Cheng |
| 33 |
[GO] |
2021―Mrz―27 |
Predicting local COVID-19 outbreaks and infectious disease epidemics based on landscape network entropy |
Rui Liu, Jiayuan Zhong, Renhao Hong, Ely Chen, Kazuyuki Aihara, Pei Chen, Luonan Chen |
| 34 |
[GO] |
2021―Feb―07 |
Evolutionary analysis and lineage designation of SARS-CoV-2 genomes |
Xiaolu Tang, Ruochen Ying, Xinmin Yao, Guanghao Li, Changcheng Wu, Yiyuli Tang, et al. (+17) Zhida Li, Bishan Kuang, Feng Wu, Changsheng Chi, Xiaoman Du, Yi Qin, Shenghan Gao, Songnian Hu, Juncai Ma, Tiangang Liu, Xinghuo Pang, Jianwei Wang, Guoping Zhao, Wenjie Tan, Yaping Zhang, Xuemei Lu, Jian Lu |
| 35 |
[GO] |
2021―Jan―19 |
The Rhinolophus affinis bat ACE2 and multiple animal orthologs are functional receptors for bat coronavirus RaTG13 and SARS-CoV-2 |
Pei Li, Ruixuan Guo, Yan Liu, Yintgtao Zhang, Jiaxin Hu, Xiuyuan Ou, et al. (+12) Dan Mi, Ting Chen, Zhixia Mu, Yelin Han, Zihan Chen, Zhewei Cui, Leiliang Zhang, Xinquan Wang, Zhiqiang Wu, Jianwei Wang, Qi Jin, Zhaohui Qian |
| 36 |
[GO] |
2021―Jan―19 |
SARS-CoV-2 nucleocapsid protein phase separates with G3BPs to disassemble stress granules and facilitate viral production |
Lingling Luo, Zhean Li, Tiejun Zhao, Xiaohui Ju, Peixiang Ma, Boxing Jin, et al. (+14) Yulin Zhou, Su He, Jinhua Huang, Xun Xu, Yan Zou, Ping Li, Aibin Liang, Jia Liu, Tian Chi, Xingxu Huang, Qiang Ding, Zhigang Jin, Cheng Huang, Yu Zhang |
| 37 |
[GO] |
2021―Jan―19 |
Binding of the SARS-CoV-2 Spike Protein to Glycans |
Wei Hao, Bo Ma, Ziheng Li, Xiaoyu Wang, Xiaopan Gao, Yaohao Li, et al. (+4) Bo Qin, Shiying Shang, Sheng Cui, Zhongping Tan |
| 38 |
[GO] |
2021―Jan―14 |
A large-scale transcriptional study reveals inhibition of COVID-19 related cytokine storm by traditional chinese medicines |
Yifei Dai, Weijie Qiang, Yu Gui, Xue Tan, Tianli Pei, Kequan Lin, et al. (+10) Siwei Cai, Liang Sun, Guochen Ning, Jianxun Wang, Hongyan Guo, Yimin Sun, Jing Cheng, Lan Xie, Xun Lan, Dong Wang |
| 39 |
[GO] |
2020―Dez―30 |
Inactivating SARS-CoV-2 by electrochemical oxidation |
Yunchuan Tu, Wei Tang, Liang Yu, Zheyi Liu, Yanting Liu, Huicong Xia, et al. (+8) Haiwei Zhang, Shiyun Chen, Jia Wu, Xiaoju Cui, Jianan Zhang, Fangjun Wang, Yangbo Hu, Dehui Deng |
| 40 |
[GO] |
2020―Dez―17 |
A theoretical exploration of the origin and early evolution of a pandemic |
Yongsen Ruan, Haijun Wen, Xionglei He, Chung-I Wu |
| 41 |
[GO] |
2020―Dez―09 |
Protoporphyrin IX and verteporfin potently inhibit SARS-CoV-2 infection in vitro and in a mouse model expressing human ACE2 |
Chenjian Gu, Yang Wu, Huimin Guo, Yuanfei Zhu, Wei Xu, Yuyan Wang, et al. (+11) Yu Zhou, Zhiping Sun, Xia Cai, Yutang Li, Jing Liu, Zhong Huang, Zhenghong Yuan, Rong Zhang, Qiang Deng, Di Qu, Youhua Xie |
| 42 |
[GO] |
2020―Dez―01 |
SARS-CoV-2 induced intestinal responses with a biomimetic human gut-on-chip |
Yaqiong Guo, Ronghua Luo, Yaqing Wang, Pengwei Deng, Tianzhang Song, Min Zhang, et al. (+8) Peng Wang, Xu Zhang, Kangli Cui, Tingting Tao, Zhongyu Li, Wenwen Chen, Yongtang Zheng, Jianhua Qin |
| 43 |
[GO] |
2020―Okt―29 |
Crystal structure of SARS-CoV-2 main protease in complex with the natural product inhibitor shikonin illuminates a unique binding mode |
Jian Li, Xuelan Zhou, Yan Zhang, Fanglin Zhong, Cheng Lin, Peter J. McCormick, et al. (+7) Feng Jiang, Jun Luo, Huan Zhou, Qisheng Wang, Yang Fu, Jingjing Duan, Jin Zhang |
| 44 |
[GO] |
2020―Okt―15 |
Dynamics of the COVID-19 basic reproduction numbers in different countries |
TianXiang Yue, Bin Fan, YaPeng Zhao, John Wilson, ZhengPing Du, Qing Wang, et al. (+6) XiaoZhe Yin, XiaoNan Duan, Na Zhao, ZeMeng Fan, Hui Lin, ChengHu Zhou |
| 45 |
[GO] |
2020―Aug―02 |
Global prediction system for COVID-19 pandemic |
Jianping Huang, Li Zhang, Xiaoyue Liu, Yun Wei, Chuwei Liu, Xinbo Lian, et al. (+10) Zhongwei Huang, Jifan Chou, Xingrong Liu, Xun Li, Kehu Yang, Jinguo Wang, Hongbing Liang, Qianqing Gu, Pengyue Du, Tinghan Zhang |
| 46 |
[GO] |
2020―Mai―05 |
Using the contact network model and Metropolis-Hastings sampling to reconstruct the COVID-19 spread on the “Diamond Princess” |
Feng Liu, Xin Li, Gaofeng Zhu |
| 47 |
[GO] |
2020―Mai―05 |
Rapid and Sensitive Detection of COVID-19 Using CRISPR/Cas12a-based Detection with Naked Eye Readout, CRISPR/Cas12a-NER |
Xinjie Wang, Mingtian Zhong, Yong Liu, Peixiang Ma, Lu Dang, Qingzhou Meng, et al. (+7) Wenwei Wan, Xiaodong Ma, Jia Liu, Guang Yang, Zifeng Yang, Xingxu Huang, Ming Liu |
| 48 |
[GO] |
2020―Apr―28 |
Clinical presentations and outcomes of SARS-CoV-2 infected pneumonia in pregnant women and health status of their neonates |
Luming Xu, Qianqian Yang, Haojun Shi, Shijun Lei, Xiaoli Liu, Yin Zhu, et al. (+14) Qiulei Wu, Xiuli Ding, Yanhong Tian, Qinghua Hu, Fenghua Chen, Zhi Geng, Xiangzhi Zeng, Lin Lin, Xuehong Cai, Min Wu, Zehua Wang, Zheng Wang, Geqing Xia, Lin Wang |
| 49 |
[GO] |
2020―Apr―14 |
A new approach to modeling the fade-out threshold of Coronavirus disease |
TianXiang Yue, ZeMeng Fan, Bin Fan, ZhengPing Du, John P. Wilson, XiaoZhe Yin, et al. (+3) Na Zhao, YingAn Wang, ChengHu Zhou |
| 50 |
[GO] |
2020―Mrz―19 |
A systematic approach is needed to contain COVID-19 globally |
Wenwu Zhao, Junze Zhang, Michael E Meadows, Yanxu Liu, Ting Hua, Bojie Fu |
| 51 |
[GO] |
2020―Mrz―03 |
The inflection point about COVID-19 may have passed |
Chaolin Gu, Jie Zhu, Yifei Sun, Kai Zhou, Jiang Gu |
| 52 |
[GO] |
2020―Feb―07 |
A data driven time-dependent transmission rate for tracking an epidemic: a case study of 2019-nCoV |
Norden E. Huang, Fangli Qiao |
|
